25058312|t|Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.
25058312|a|In a previous work we have shown that exposure to aluminum (Al) chloride (AlCl3) enhanced the neurotoxicity of the amyloid beta(25-35) fragment (Abeta(25-35)) in neuroblastoma cells and affected the expression of Alzheimer's disease (AD)-related genes. Caffein, a compound endowed with beneficial effects against AD, exerts neuroprotection primarily through its antagonist activity on A2A adenosine receptors (A2AR), although it also inhibits A1Rs with similar potency. Still, studies on the specific involvement of these receptors in neuroprotection in a model of combined neurotoxicity (Abeta(25-35)+AlCl3) are missing. To address this issue, cultured SH-SY5Y cells exposed to Abeta(25-35)+AlCl3 were assessed for cell viability, morphology, intracellular ROS activity and expression of apoptosis-, stress- and AD-related proteins. To define the role of A1R and A2ARs, pretreatment with caffein, specific receptor antagonists (DPCPX or SCH58261) or siRNA-mediated gene knockdown were delivered. Results indicate that AlCl3 treatment exacerbated Abeta(25-35) toxicity, increased ROS production, lipid peroxidation, beta-secretase-1 (BACE1) and amyloid precursor protein (APP). Interestingly, SCH58261 successfully prevented toxicity associated to Abeta(25-35) only, whereas pretreatment with both DPCPX and SCH58261 was required to fully avert Abeta(25-35)+AlCl3-induced damage, suggesting that A1Rs might also be critically involved in protection during combined toxicity. The effects of caffein were mimicked by both N-acetyl cysteine, an antioxidant, and desferrioxamine, likely acting through distinct mechanisms. Altogether, our data establish a novel protective function associated with A1R inhibition in the setting of combined Abeta(25-35)+AlCl3 neurotoxicity, and expand our current knowledge on the potential beneficial role of caffein to prevent AD progression in subjects environmentally exposed to aluminum.
25058312	28	31	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;CorrespondingGene:23621;RS#:28917234;CorrespondingSpecies:9606
25058312	85	98	neuroblastoma	Disease	MESH:D009447
25058312	116	133	aluminum chloride	Chemical	MESH:D000077410
25058312	185	207	aluminum (Al) chloride	Chemical	MESH:D000077410
25058312	209	214	AlCl3	Chemical	MESH:D000077410
25058312	229	242	neurotoxicity	Disease	MESH:D020258
25058312	250	269	amyloid beta(25-35)	Gene	351
25058312	280	292	Abeta(25-35)	Gene	351
25058312	297	310	neuroblastoma	Disease	MESH:D009447
25058312	348	367	Alzheimer's disease	Disease	MESH:D000544
25058312	369	371	AD	Disease	MESH:D000544
25058312	388	395	Caffein	Chemical	-
25058312	448	450	AD	Disease	MESH:D000544
25058312	523	543	 adenosine receptors	Gene	135
25058312	520	523	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;CorrespondingGene:23621;RS#:28917234;CorrespondingSpecies:9606
25058312	545	549	A2AR	Gene	135
25058312	709	722	neurotoxicity	Disease	MESH:D020258
25058312	724	736	Abeta(25-35)	Gene	351
25058312	737	742	AlCl3	Chemical	MESH:D000077410
25058312	789	796	SH-SY5Y	CellLine	CVCL:0019
25058312	814	826	Abeta(25-35)	Gene	351
25058312	827	832	AlCl3	Chemical	MESH:D000077410
25058312	893	896	ROS	Chemical	-
25058312	948	950	AD	Disease	MESH:D000544
25058312	1024	1031	caffein	Chemical	-
25058312	1064	1069	DPCPX	Chemical	MESH:C051360
25058312	1073	1081	SCH58261	Chemical	MESH:C098657
25058312	1154	1159	AlCl3	Chemical	MESH:D000077410
25058312	1182	1194	Abeta(25-35)	Gene	351
25058312	1195	1203	toxicity	Disease	MESH:D064420
25058312	1215	1218	ROS	Chemical	-
25058312	1231	1236	lipid	Chemical	MESH:D008055
25058312	1251	1267	beta-secretase-1	Gene	23621
25058312	1269	1274	BACE1	Gene	23621
25058312	1280	1305	amyloid precursor protein	Gene	351
25058312	1328	1336	SCH58261	Chemical	MESH:C098657
25058312	1360	1368	toxicity	Disease	MESH:D064420
25058312	1383	1395	Abeta(25-35)	Gene	351
25058312	1433	1438	DPCPX	Chemical	MESH:C051360
25058312	1443	1451	SCH58261	Chemical	MESH:C098657
25058312	1480	1492	Abeta(25-35)	Gene	351
25058312	1493	1498	AlCl3	Chemical	MESH:D000077410
25058312	1600	1608	toxicity	Disease	MESH:D064420
25058312	1625	1632	caffein	Chemical	-
25058312	1655	1672	N-acetyl cysteine	Chemical	MESH:D000111
25058312	1694	1709	desferrioxamine	Chemical	MESH:D003676
25058312	1871	1883	Abeta(25-35)	Gene	351
25058312	1884	1889	AlCl3	Chemical	MESH:D000077410
25058312	1890	1903	neurotoxicity	Disease	MESH:D020258
25058312	1974	1981	caffein	Chemical	-
25058312	1993	1995	AD	Disease	MESH:D000544
25058312	2047	2055	aluminum	Chemical	MESH:D000535
25058312	Association	RS#:28917234;HGVS:c.2A>A;CorrespondingGene:23621	MESH:D009447
25058312	Association	MESH:D000077410	RS#:28917234;HGVS:c.2A>A;CorrespondingGene:23621
25058312	Positive_Correlation	MESH:D000077410	MESH:D064420
25058312	Positive_Correlation	MESH:D000077410	351
25058312	Positive_Correlation	MESH:D000077410	23621
25058312	Positive_Correlation	MESH:D064420	351
25058312	Negative_Correlation	MESH:C098657	MESH:D064420
25058312	Positive_Correlation	MESH:D000077410	MESH:D020258
25058312	Negative_Correlation	MESH:C098657	351
25058312	Association	MESH:D000077410	MESH:D000544
25058312	Negative_Correlation	MESH:C098657	MESH:D000077410
25058312	Positive_Correlation	MESH:D000077410	MESH:D009447
25058312	Association	MESH:D000077410	MESH:D008055
25058312	Association	MESH:D009447	23621

